The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Jan 2023)
Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy
Geeta S. Bhagwat,
Rajani B. Athawale,
Rajeev P. Gude,
Shadab Md,
Nabil A. Alhakamy,
Usama A. Fahmy,
Prashant Kesharwani
Affiliations
Geeta S. Bhagwat
H. K. College of Pharmacy, Mumbai, India
Rajani B. Athawale
Prin. K. M. Kundanani College of Pharmacy, Mumbai, India
Rajeev P. Gude
Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India
Shadab Md
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
Nabil A. Alhakamy
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
Usama A. Fahmy
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
Prashant Kesharwani
Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
DOI
https://doi.org/10.3389/fphar.2022.1123542
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
breast cancer
cancer
solid lipid nanoparticles
tamoxifen
targeted drug delivery
WeChat QR code
Close